COMMUNIQUÉS West-GlobeNewswire

Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
28/09/2026
New expert-led services platform will help healthcare providers develop, implement, and optimize proton therapy and advanced radiation oncology programs across the full care delivery lifecycle PHILADELPHIA, Pa., and [...]
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update
28/09/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 28, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
JJP Biologics to Present Data Showing the Potential of Nebaprubart for Linear IgA Dermatosis (LAD) at Two Key Upcoming Scientific Conferences
28/09/2026
Positive interim data from Phase Ib proof-of-concept trial will be presented at the IPPF Scientific Symposium on Pemphigus and Pemphigoid and at EADV Congress 2026 Data positions nebaprubart as a potential therapy [...]
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2026 et fait un point sur ses activités
28/09/2026
11,1 millions d’euros de trésorerie au 30 juin 2026 ; horizon de financement confirmé jusqu’à fin décembre 2026 La Société poursuit activement ses interactions avec les investisseurs institutionnels aux États-Unis et en [...]
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2026, and Provides Business Update
28/09/2026
€11.1 million cash position as of June 30, 2026; cash runway confirmed through December 2026 The Company continues to engage actively with institutional investors in the United States and Europe to extend its cash [...]
HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors
28/09/2026
First-in-class KRAS-payload leveraging synchronized EGFR inhibition HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 27, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM: [...]
ITM and Lumara Bio Announce Real-World Re-treatment Data and Dosimetry Results from COMPETE for ¹⁷⁷Luedotreotide (ITM-11) in GEP-NETs at ASTRO 2026
27/09/2026
Investigator-led SwissNET registry analysis showed longer real-world progression-free and overall survival for patients re-treated with 177 Lu-edotreotide compared to those receiving non-radiopharmaceutical systemic [...]
IBA lance le fantôme QUASAR® Penta-Guide Performance
27/09/2026
Plus de 25 tests d'imagerie et de contrôle qualité machine réunis en une seule configuration. Louvain-la-Neuve, Belgique, 27 septembre 2026 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie [...]
IBA Launches QUASAR® Penta-Guide Performance Phantom
27/09/2026
More than 25 imaging and machine QA tests in one setup. Louvain-la-Neuve, Belgium, 27 September 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global [...]
TamaBio to Showcase Synthetic Biomembrane Technology at ACS Clinical Congress 2026 in Washington, D.C.
27/09/2026
Japanese medical technology company will introduce U.S. surgeons and industry partners to its DuraBeam® and PeriBeam® devices WASHINGTON, Sept. 27, 2026 (GLOBE NEWSWIRE) -- TamaBio Company Limited , a Japanese medical [...]
The Future of Radiotherapy is Here: Siemens Healthineers Launches Accela
27/09/2026
The Accela radiotherapy solution is engineered around NeoArc dynamic modulated arc therapy (DMAT), a breakthrough technique combining speed and precision Boston, Sept. 27, 2026 (GLOBE NEWSWIRE) -- Siemens Healthineers [...]
Lanier Recovery Center launches virtual IOP for adults across Georgia
26/09/2026
Joint Commission-accredited outpatient program in Suwanee expands access to structured addiction treatment for people who can't attend in person Suwanee, GA, Sept. 26, 2026 (GLOBE NEWSWIRE) -- Lanier Recovery Center, a [...]
Crescent Biopharma Announces Grants of Inducement Awards
25/09/2026
WALTHAM, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
25/09/2026
Adjustments have no impact on cash and cash equivalents, cash runway, or business operations. Restatement is expected to reduce previously reported stock-based compensation expense, warrant liabilities, and accumulated [...]
BioAge Labs to Present at Upcoming Investor Conferences
25/09/2026
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for cardiometabolic [...]
Quest PharmaTech Announces Change of Chief Executive Officer
25/09/2026
EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through [...]
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
25/09/2026
SAN DIEGO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today [...]
Family-Owned Canadian Supplement Brand Herba Ranks No. 81 on The Globe and Mail’s List of Canada’s Top Growing Companies
25/09/2026
With over 100 Canadian-made supplements, Herba earns its second consecutive appearance and ranks No. 9 in the Health Care & Wellness category. Toronto, ONTARIO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Herba Health Inc. ( [...]
Microbot Medical® Highlights Growth Strategy
25/09/2026
User Survey Demonstrates High Satisfaction of the LIBERTY System Expansion of Sales Footprint Expands to Western U.S. as Company Secures First California Customer HINGHAM, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -- [...]

Pages